Bristol Myers Squibb to Host Hematology-Focused Investor Event
Bristol Myers Squibb (NYSE: BMY) will host a virtual investor event on Thursday, December 11, 2025 following the conclusion of the American Society of Hematology Annual Meeting and Exposition.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
The company will host a webcast beginning at 9:00 a.m. ET, which is accessible here. Company representatives will provide investors and analysts an overview of the company’s Hematology development strategy and review recent data.
A replay of the webcast will be available at http://investor.bms.com approximately three hours after the event concludes. Materials related to the webcast will be available at http://investor.bms.com at the start of the presentation.
About Bristol Myers Squibb: Transforming Patients' Lives Through Science
At Bristol Myers Squibb, our mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases. We are pursuing bold science to define what's possible for the future of medicine and the patients we serve. For more information, visit us at BMS.com and follow us on LinkedIn, X, YouTube, Facebook and Instagram.
corporatefinancial-news
View source version on businesswire.com: https://www.businesswire.com/news/home/20251124331455/en/
Media Relations:
media@bms.com
Investor Relations:
investor.relations@bms.com
Source: Bristol Myers Squibb